| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443205 | European Journal of Cancer | 2014 | 9 Pages |
Abstract
Patients with BRAF mutations experienced rapid progression of metastatic disease with locoregional recurrence rarely seen in isolation, supporting incorporation of BRAF status into melanoma staging and use of BRAF/MEK inhibitors post-TLND.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrew P. Barbour, Yue Hang Tang, Nicola Armour, Ken Dutton-Regester, Lutz Krause, Kelly A. Loffler, Duncan Lambie, Bryan Burmeister, Janine Thomas, B. Mark Smithers, Nicholas K. Hayward,